| Literature DB >> 31703821 |
Alan Menter1, Kelly M Cordoro2, Dawn M R Davis3, Daniela Kroshinsky4, Amy S Paller5, April W Armstrong6, Cody Connor7, Boni E Elewski7, Joel M Gelfand8, Kenneth B Gordon9, Alice B Gottlieb10, Daniel H Kaplan11, Arthur Kavanaugh12, Matthew Kiselica13, Dario Kivelevitch1, Neil J Korman14, Mark Lebwohl15, Craig L Leonardi16, Jason Lichten13, Henry W Lim17, Nehal N Mehta18, Sylvia L Parra19, Arun L Pathy20, Elizabeth A Farley Prater21, Reena N Rupani15, Michael Siegel22, Benjamin Stoff23, Bruce E Strober24, Emily B Wong25, Jashin J Wu26, Vidhya Hariharan27, Craig A Elmets7.
Abstract
Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.Entities:
Keywords: clinical guidelines for psoriasis; comorbidities; dermatology; guidelines; pediatric; pediatric psoriasis; psoriasis; psoriasis guidelines; skin disease
Year: 2019 PMID： 31703821 DOI： 10.1016/j.jaad.2019.08.049
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527